New injectors and the social context of injection initiation

International Journal of Drug Policy

Volumn 20, Issue 4, 2009, Pages 317-323

  Harocopos, Alex ^a   Goldsamt, Lloyd A ^a   Kobrak, Paul ^a   Jost, John J ^a   Clatts, Michael C ^a  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

Initiation; Injecting drug use; Narratives; Social setting

Indexed keywords

DIAMORPHINE;

ADOLESCENT; ADULT; ARTICLE; BEHAVIOR CHANGE; DRUG USE; FEMALE; HARM REDUCTION; HUMAN; INTERVIEW; LONGITUDINAL STUDY; MALE; MOTIVATION; PRIORITY JOURNAL; SEXUALITY; SOCIAL ENVIRONMENT;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; HUMANS; INJECTIONS; MALE; PEER GROUP; SOCIAL ENVIRONMENT; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 66749125032     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2008.06.003     Document Type: Article

References (46)

1. Bravo M., Barrio G., de la Fuente L., Royuela L., Domingo L., and Silva T. Reasons for selecting an initial route of heroin administration and for subsequent transitions during a severe HIV epidemic. Addiction 98 (2003) 749-760
2. Casriel C., Des Jarlais D.C., Rodriguez R., Friedman S.R., Stepherson B., and Khuri E. Working with heroin sniffers: Clinical issues in preventing drug injection. Journal of Substance Abuse Treatment 7 (1990) 1-10
3. Center for Disease Control & Prevention. Trends in injection drug use among persons entering addiction treatment-New Jersey, 1992-1999. MMWR 50 19 (2001) 378-381
4. Chitwood D.D., Sanchez J., Comerford M., Page J.B., McBride D.C., and Kitner K.R. First injection and current risk factors for HIV among new and long-term injection drug users. AIDS Care 12 3 (2000) 313-320
5. Coggans N., and McKellar S. Drug use among peers: Peer pressure or peer preference?. Drugs: Education, Prevention and Policy 1 1 (1994) 15-26
6. Crofts N., Louie R., Rosenthal D., and Jolley D. The first hit: Circumstance surrounding initiation into injecting. Addiction 91 8 (1996) 1187-1196
7. Darke S. Self-report among injecting drug users: A review. Drug and Alcohol Dependence 51 3 (1998) 253-263
8. Darke S., Cohen J., Ross J., Hando J., and Hall W. Transitions between routes of administration of regular amphetamine users. Addiction 89 (1994) 1077-1083
9. Des Jarlais D., Casriel C., Freidman S., and Rosenblaum A. AIDS and the transition to illicit drug injection-results of a randomised trial prevention program. British Journal of Addiction 87 (1992) 493-498
10. Des Jarlais D.C., Friedman S.R., Perlis T., Chapman T.F., Sotheran J.L., Paone D., et al. Risk behaviour and HIV infection among new drug injectors in the era of AIDS in New York City. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 20 (1999) 67-72
11. Duff C. The pleasure in context. International Journal of Drug Policy (2007) 10.1016/j.drugpo.2007.07.003
12. Dunn J., and Laranjeira R. Transitions in the route of cocaine administration-characteristics, direction and associated variables. Addiction 94 (1999) 813-824
13. Dwyer R. Privileging pleasure: Temazepam injection in a heroin marketplace. International Journal of Drug Policy (2007) 10.1016/j.drugpo. 2007.09.004
14. Frank B. An overview of heroin trends in New York City: Past, present and future. Mount Sinai Journal of Medicine 67 5/6 (2000) 340-346
15. Frank B., and Galea J. Current drug use trends in New York City. Epidemiologic trends in drug abuse. Proceedings for the December 1998 Community Epidemiology Work Group (1998), National Institute on Drug Abuse, Rockville, MD 181-189
16. Fitzgerald J.L., Louie R., Rosenthal D., and Crofts N. The meaning of the rush for initiates to injecting drug use. Contemporary Drug Problems 26 3 (1999) 481-504
17. Fuller C.M., Vlahov D., Ompad D.C., Shah N., Arria A., and Strathdee S.A. High-risk behaviours associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: A case-control study. Drug and Alcohol Dependence 66 (2002) 189-198
18. Gamella J.F. The spread of intravenous drug use and AIDS in a neighbourhood in Spain. Medical Anthropology Quarterly 8 2 (1994) 131-160
19. Garfein R.S., Doherty M.C., Monterosso E.R., Thomas D.L., Nelson K.E., and Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18 (1998) S11-S19
20. Giddings D., Christo G., and Davy J. Reasons for Injecting and not injecting: A qualitative study to inform therapeutic intervention. Drugs: Education, Prevention and Policy 10 1 (2003) 95-104
21. Grund, J. (1998). From the straw to the needle? Determinants of heroin administration routes In J. Inciardi & L. D. Harrison (Eds.) Heroin in the Age of Crack Cocaine. Drugs, Health & Social Policy Series Ed. (pp. 215-258) Newbury Park, CA: Sage Publications.
22. Hamid A., Curtis R., McCoy K., McGuire J., Conde A., Bushell W., et al. The heroin epidemic in New York City: Current status and prognoses. Journal of Psychoactive Drugs 29 4 (1997) 375-391
23. Hunt L.G., and Chambers C. Heroin epidemics: A study of heroin use in the United States 1965-1975 (1976), Spectrum, New York
24. Hunt N., Stillwell G., Taylor C., and Griffiths P. Evaluation of a brief intervention to prevent initiation into injecting. Drugs: Education, Prevention and Policy 5 2 (1998) 185-194
25. Latkin C. Outreach in natural settings: The use of peer leaders for HIV prevention among injecting drug users' networks. Public Health Reports 113 1 (1998) 151-159
26. Maclean S. It might be a scummy-arsed drug, but it's a sick buzz: Chroming and pleasure. Contemporary Drug Problems 32 (2005) 295-318
27. Miller M. A model to explain the relationship between sexual abuse and HIV risk among women. AIDS Care 11 (1999) 3-20
28. Muhr, T. (2004). User's manual for Atlas. ti. 5.0. Berlin, Germany: Atlas, ti Scientific Software Development.
29. Neaigus A., Gyarmathy A., Miller M., Frajzyngier V., Friedman S.R., and Des Jarlais D.C. Transitions to injecting drug use among non-injecting heroin users: Social network influence and individual susceptibility. Journal Acquired Immune Deficiency Syndrome 41 4 (2006) 493-503
30. Neaigus A., Miller M., Freidman S.R., Hagen L., Sifaneck S.J., Ildefonso G., et al. Potential risk factors for the transition to injecting among non-injecting heroin users: A comparison of former injectors and never injectors. Addiction 96 6 (2001) 847-860
31. Nelson K.E., Galai N., Safaeian M., Strathdee S.A., Celentano D., and Vlahov D. Temporal trends in the incidence of HIV infection and risk behaviour among injecting drug users in Baltimore, Maryland 1988-1998. American Journal of Epidemiology 156 (2002) 641-653
32. NIDA. (1996). Director's Report to the National Advisory Council on Drug Abuse.
33. Ouellet L., Rahimian A., and Wiebel W. The onset of drug injection among sex partners of injection drug users. AIDS Education and Prevention 10 (1998) 341-350
34. Roy E., Haley N., Leclerc P., Cedras L., and Boivin J.-F. Drug injection among street youth: The first time. Addiction 97 (2002) 1003-1009
35. Scott G. "They got their program, and I got mine": A cautionary tale concerning the ethical implications of using respondent-driven sampling to study injection drug users. International Journal of Drug Policy 19 (2008) 42-51
36. Scott J. Pharmaceutical aspects of injecting. In: Pates R., McBride A., and Arnold K. (Eds). Injecting drugs (2005), Blackwell Publishing, Oxford
37. Sherman S.G., Smith L., Laney G., and Strathdee S.A. Social influences on the transition to injection drug use among young heroin sniffers: A qualitative analysis. International Journal of Drug Policy 13 (2002) 113-120
38. Stenbacka M. Initiation into intravenous drug abuse. Acta Psychiatrica Scandinavica 81 (1990) 459-462
39. Stillwell G., Hunt N., Taylor C., and Griffiths P. The modelling of injecting behaviour and initiation into injecting. Addiction Research 7 5 (1999) 447-459
40. Strang J., Des Jarlais D., Griffiths P., and Gossop M. The study of transitions in the route of drug use: From one route to another. British Journal of Addiction 87 (1992) 473-483
41. Thorpe L., Ouellet L.J., Levy J.R., Williams I.T., and Monterroso E.R. Hepatitis C virus infection: Prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago 1997-1999. Journal of Infectious Diseases 182 (2000) 1588-1594
42. Treloar C., and Abelson J. Information exchange among injecting drug users: A role for an expanded peer education workforce. International Journal of Drug Policy 16 (2005) 46-53
43. Valentine K., and Fraser S. Trauma, damage and pleasure: Rethinking problematic drug use. International Journal of Drug Policy (2007) 10.1016/j.drugpo.2007.08.001
44. van Ameijden E.J., van den Hoek J.A.R., Hartgers C., and Coutinho R.A. Risk factors for the transition from non-injection to injection drug use and accompanying AIDS risk behaviour in a cohort of drug-users. American Journal of Epidemiology 139 (1994) 1153-1163
45. Vlahov D., Fuller C.M., Ompad D.C., Galea S., and Des Jarlais D.C. Updating the infection risk reduction hierarchy: Preventing transition to injecting. Journal of Urban Health 81 1 (2004) 14-19
46. Witteveen E., van Ameijden E., and Schippers G.M. Motives for and against injecting drug use among young adults in Amsterdam: Qualitative findings and consideration for disease prevention. Substance Use and Misuse 4 (2006) 1001-1016